COVID-19 and immunomodulator/immunosuppressant use in dermatology
COVID-19 and immunomodulator/immunosuppressant use in dermatology is a paper indexed in ScholarIQ from OpenAlex.
How many citations does COVID-19 and immunomodulator/immunosuppressant use in dermatology have?
COVID-19 and immunomodulator/immunosuppressant use in dermatology has 100 citations in the OpenAlex counts ScholarIQ stores.
When was COVID-19 and immunomodulator/immunosuppressant use in dermatology published?
COVID-19 and immunomodulator/immunosuppressant use in dermatology has 2020 year in the ScholarIQ index.
What is the open-access status of COVID-19 and immunomodulator/immunosuppressant use in dermatology?
COVID-19 and immunomodulator/immunosuppressant use in dermatology has bronze oa status in the ScholarIQ index.
What is the DOI of COVID-19 and immunomodulator/immunosuppressant use in dermatology?
The DOI for COVID-19 and immunomodulator/immunosuppressant use in dermatology is on the source record.
What is the PMID of COVID-19 and immunomodulator/immunosuppressant use in dermatology?
The PMID for COVID-19 and immunomodulator/immunosuppressant use in dermatology is on the source record.
What is the OpenAlex record for COVID-19 and immunomodulator/immunosuppressant use in dermatology?
The OpenAlex for COVID-19 and immunomodulator/immunosuppressant use in dermatology is on the source record.